{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:11:49Z","timestamp":1790190709583,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jneuroim.2005.08.017","type":"journal-article","created":{"date-parts":[[2005,9,23]],"date-time":"2005-09-23T09:48:14Z","timestamp":1127468894000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravis"],"prefix":"10.1016","volume":"170","author":[{"given":"Shigeaki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekata","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kortaro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.08.017_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.1990.tb05440.x","article-title":"Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin","volume":"82","author":"Aarli","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib3","series-title":"Harrison's Principles of Internal Medicine","year":"2001"},{"key":"10.1016\/j.jneuroim.2005.08.017_bib4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.08.017_bib5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib6","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in patients with MG: characteristics and long-term outcome","volume":"59","author":"Evoli","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.08.017_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0404.1984.tb00817.x","article-title":"Heart disease in myasthenia gravis","volume":"70","author":"Hofstad","year":"1984","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.08.017_bib11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI116343","article-title":"Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis","volume":"91","author":"Kuwana","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1529-0131(199902)42:2<275::AID-ANR9>3.0.CO;2-P","article-title":"Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes","volume":"42","author":"Kuwana","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib13","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/art.10521","article-title":"Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay","volume":"46","author":"Kuwana","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1749-6632.1998.tb10955.x","article-title":"Expression of muscle proteins in thymomas of patients with myasthenia gravis","volume":"841","author":"Liyanage","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0076-6879(94)41070-4","article-title":"Rapid determination of endoprotease specificity using peptide mixture and Edman degradation analysis","volume":"241","author":"Masiarz","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0021-9258(17)43698-2","article-title":"Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with scleroderma-polymyositis overlap syndrome","volume":"259","author":"Mimori","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410320419","article-title":"Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma","volume":"32","author":"Mygland","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archneur.1974.00490370053007","article-title":"Idiopathic giant cell polymyositis. Report of a case and review of the syndrome","volume":"31","author":"Namba","year":"1974","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/brain\/116.2.453","article-title":"Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review","volume":"116","author":"Newsom-Davis","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.08.017_bib20","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1093\/nar\/18.23.7160","article-title":"Sequence of a human fetal skeletal muscle potassium channel cDNA related to RCK4","volume":"18","author":"Philipson","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib21","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1016\/S0021-9258(19)41192-7","article-title":"Two-dimensional gel analysis of soluble proteins. Characterization of guinea pig exocrine pancreatic proteins","volume":"250","author":"Scheele","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1096\/fasebj.5.3.2001794","article-title":"Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle","volume":"5","author":"Tamkun","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib24","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/j.1460-9568.1995.tb00641.x","article-title":"Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain","volume":"7","author":"Veh","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib25","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","article-title":"Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis","volume":"157","author":"Wakkach","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib26","first-page":"H1599","article-title":"Regional contributions of KV1.4, KV4.2, and KV4.3 to transient outward K+ current in rat ventricle","volume":"276","author":"Wickenden","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.164.4.1043","article-title":"Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin","volume":"164","author":"Williams","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2005.08.017_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature00978","article-title":"The voltage-gated potassium channels and their relatives","volume":"419","author":"Yellen","year":"2002","journal-title":"Nature"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572805003668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572805003668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:40Z","timestamp":1759046560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572805003668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0165572805003668"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.08.017","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}